Arbutus to Participate at H.C. Wainwright Global Life Sciences Conference
WARMINSTER, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Year: 2021
Ayala Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
REHOVOT, Israel and WILMINGTON, Del., March 02, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company...
eGenesis Announces $125 Million Series C Financing
Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studiesCAMBRIDGE, Mass., March 02,...
Eledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference
IRVINE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused...
Histogen to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential...
Spectral Medical to participate at the upcoming H.C. Wainwright Global Life Sciences Conference
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company...
Validation Institute confirms Proactive MD’s innovative model delivers high-quality care at a lower cost — even during a global pandemic
Proactive MD remains the only company in the primary care category to receive such validation for cost savingsGREENVILLE, March 02,...
New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs
MELBOURNE, Australia, March 02, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology...
Protech Home Medical Reports Record First Quarter Fiscal 2021 Financial Results
Posts Revenue Growth of 32% And Adjusted EBITDA Growth of 53% Recurring Revenue Grows to 75% of Total Revenue CINCINNATI,...
Chiasma to Participate in the H.C. Wainwright Global Life Sciences Conference
NEEDHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company, today announced that management...
Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...
Nanox Announces Fourth Quarter 2020 Results and Provides Business Update
Successfully demonstrates the Nanox.ARC in range of 2D and 3D imaging applications at the 2020 Radiology Society of North America...
Vincerx Pharma Strengthens Management Team with Three New Appointments
Company names new Chief Medical Officer, Chief Scientific Officer, and General Counsel and Chief Legal OfficerPALO ALTO, Calif., March 02,...
Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations...
Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference
LEXINGTON, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis
Registry will continue to advance the understanding of the clinical outcomes and management of recurrent pericarditis in partnership with the...
Avadel Pharmaceuticals Announces Publication of Once-Nightly FT218 Pharmacokinetic Studies
DUBLIN, Ireland, March 02, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational,...
Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial
Awakn intends to run a Phase III trial for 'Ketamine-Assisted Psychotherapy for Alcohol Use Disorder'London, United Kingdom--(Newsfile Corp. - March...
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options
Oakville, Ontario--(Newsfile Corp. - March 2, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...